Starting from the first reports of complement disease-associated mutations [1], genetic alterations in four CFH (complement factor H), CFI (complement factor I), MCP (membrane cofactor protein) and complement C3 have increasingly been associated with immune disorders [2–4]. This evidence concerns the gene CD46 and immune system disorder.